Sanergy Group Ltd. has announced a further change in the use of net proceeds from its listing and rights issue. The company plans to direct capital expenditure toward optimizing and maintaining existing production facilities and equipment, with the aim of reducing production costs, mitigating operational risks, and enhancing profitability in 2026. Approximately HK$11.0 million from the rights issue will be allocated to the development and expansion of the graphite electrodes business and/or the GAM business, including upgrades to production facilities and investments in projects with strategic synergies. The remaining proceeds of HK$2.7 million from the listing and HK$11.0 million from the rights issue will also be applied to these capital initiatives. Additionally, the funds will support procurement of raw materials, payment for subcontracting and conversion costs, and other operating expenses to ensure fulfillment of expected customer orders in the first half of 2026. The board will continue to assess and may revise the plan for use of unutilised proceeds in response to changing market conditions.